Modification of chronic oral nonsteroidal anti-inflammatory drug (NSAID) requirement; feasibility, patient benefit and cost-effectiveness.
Completed
- Conditions
- Osteoarthritisregional locomotor painMusculoskeletal DiseasesOther symptoms and signs involving the nervous and musculoskeletal systems
- Registration Number
- ISRCTN14558398
- Lead Sponsor
- HS R&D Regional Programme Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 260
Inclusion Criteria
Two general practices with computer generated register data will be invited to participate. Up to 260 patients receiving regular prescriptions for NSAIDs for regional locomotor pain will be identified according to the following criteria.
1. Adult (18 years or older, no upper age limit)
2. Oral NSAID prescriptions to cover at least 6 of the previous 12 months
3. Last prescription within 6 weeks of induction into study
4. Osteoarthritis or regional locomotor pain (e.g. shoulder lesion, neck pain, back pain) as the reason for prescription
Exclusion Criteria
Defined inflammatory arthritis (e.g. rheumatoid arthritis, ankylosin spondylitis, gout), bone malignancy or non-locomotor pain as reason for prescription (obtained from GP records)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration